A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression - Clinical Trial NCTNCT07023627

Business Opportunities for NCT07023627

Connect with principal investigators, study coordinators, and key decision makers for this PHASE2 trial studying investigational therapy for Ovarian Neoplasms, Carcinoma, Ovarian Epithelial.

Clinical Trial Information

Study Sponsor

Sponsor information available

Drug/Intervention

Study intervention details available

Therapeutic Area

Ovarian Neoplasms, Carcinoma, Ovarian Epithelial

Study Phase

PHASE2

Study Status

NOT_YET_RECRUITING

NCT Number

NCTNCT07023627

Find Contact Information

Access exclusive contact details for:

• Principal investigators and sub-investigators
• Study coordinators and research staff
• Site directors and facility contacts
• Sponsor representatives and CRO partners
• Business development professionals
• Clinical operations managers

Clinical Trial Locations

This study has multiple locations across various countries.

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

• Discover clinical trials before competitors
• Access exclusive contact information
• Track sponsor pipelines and opportunities
• Connect with decision makers directly
• Win more business partnerships